 Viridian Therapeutics, Inc. NASDAQ:VRDN Q3 2022 Earnings Conference Call November 14, 2022 8:00 AM ET Company Participants John Jordan - Vice President of Investor Relations Jonathan Violin - President Chief Executive Officer Barrett Katz - Chief Medical Officer Kristian Humer - Chief Financial Officer Chief Business Officer Conference Call Participants Rami Katkhuda - LifeSci Capital Gavin Clark-Gartner - Evercore ISI Thomas Smith - SVB Securities Laura Chico - Wedbush Securities Kalpit Patel - B. Riley Securities Jason Butler - JMP Securities Operator Greetings and welcome to Viridian Therapeutics Third Quarter 2022 Earnings Call. 